LYFE Capital
Venture capitalMenlo Park · Seed–Late Stage · 16 people tracked
Also known as LYFE CAPITAL GLOBAL PARTNER LIMITED · LYFE CAPITAL INVESTMENT MANAGEMENT (HONG KONG) LIMITED · LYFE CAPITAL INVESTMENT MANAGEMENT (SHANGHAI) CO., LTD. · LYFE CAPITAL INVESTMENT MANAGEMENT LIMITED · LYFE U.S LLC
Investment thesis
LYFE Capital is a healthcare investment platform led by investment veterans and operators who have navigated multiple market cycles. Operating from five global offices in Asia and the United States, the firm targets critical healthcare supply chain assets, specialized product platforms, and next-generation R&D services. Its aim is to help these companies grow significant and resilient revenues by tapping into global mature markets.
Source: firm website, verified Aug 25, 2026.
Team · 16 people
from the firm's website & public directories
.avif)
What they invest in
from 12 of 23 portfolio companiesBiotech ×11Healthtech ×9Medical Devices ×4Advanced Manufacturing ×2Deep Tech ×2AI & Machine Learning ×1Digital Health ×1New Materials ×1
HQs:United States×5China×1Taiwan×1
Investments · 23 tracked
founders shown can be your intro pathBy year:2025 · 12024 · 12020 · 13 dated
Cytotronics develops Pixel, a semiconductor-to-live-cell interface platform that measures cell viability, morphology, electrophysiology, and metabolism at single-cell resolution across any cell type or 3D organoid system.
BiotechDeep TechSemiconductorsBoston, US
Jeffrey Abbott(Co-Founder & CEO)Vince Wu(Co-Founder & CTO)Duane Sword(Co-Founder & CBO)inDonhee Ham(Scientific Co-Founder)Hongkun Park(Scientific Co-Founder)Vince (Wenxuan) Wu(Founder)in
Co-investorsAnzu PartnersBantam GroupDraper AssociatesBoxOne Ventures
iECURE is a clinical-stage biotechnology company developing in vivo genome editing therapies that insert a functional copy of a gene into a patient's genome to treat rare, life-threatening genetic diseases in children.
BiotechHealthtechMedical Devices
James M. Wilson(Scientific Founder)Joseph Truitt(CEO & Board Member)Paul Firuta(COO)Alex Monteith(Chief Business Officer)David Garrett(CFO)Gabriel M. Cohn(Chief Medical Officer)
Co-investorsOrbiMedVersant Ventures
Bora Pharmaceuticals is a pharmaceutical services company offering CDMO (contract development and manufacturing) for both small molecule and large molecule/biologics products, alongside its own drug development focused on specialty pharma and rare diseases.
Advanced ManufacturingBiotechHealthtech
Bobby Sheng(Founder)
New Jersey-based end-to-end data service CRO leveraging Asia to improve operational efficiency.
BiotechCleveland, US
Arnon Chait(Executive Officer, Director)ANDREW SUMMERS(Executive Officer)
BoardNOEL JEE(Director)inJOSEPH RICH(Director)SAMEER ROHATGI(Director)DARA WRIGHT(Director)
Co-investorsJobsOhio VenturesJumpstart VenturesSofinnova Ventures
China-based surgical robotics company with approvals for both multi-port and single-port endoscopy systems.
Singapore-based specialized MedTech contract development and manufacturing organization (CDMO) with a strong foothold in the endoscopic sector.
HiFiBiO Therapeutics develops immunotherapies for patients with high unmet medical needs, using its Drug Intelligence Science (DIS) platform that combines single cell technology with AI/ML analytics.
AI & Machine LearningBiotechHealthtech
Liang Schweizer(Founder)in
Co-investorsB Capital GroupB4 CapitalTrinity Innovation Bioventure SingaporeIDG CapitalLegend CapitalSequoia Capital
An enterprise that develops and commercializes biomedical materials and biopharmaceutical products, including Class III and Class II medical devices, dermal fillers, facial threads, and proteins/peptides for medical aesthetics, dermatology, surgery, metabolic disease, and professional skincare.
BiotechHealthtechMedical DevicesWellness & FitnessBeijing, CN
South Korean energy-based medical aesthetic device company with diversified product lines and fast iteration.
Medical device company in China's minimally invasive surgery market; LYFE Fund I portfolio company taken public.
First-in-class ADC platform partnered with Roche and BioNTech.
Molecular Assemblies uses a Fully Enzymatic Synthesis (FES) technology to produce long, pure, and accurate synthetic DNA oligonucleotides, up to 400 bases, without post-synthesis purification.
BiotechDeep TechNew MaterialsSan Diego, US
J. William Efcavitch, Ph.D.(Treasurer and Chief Scientific Officer)Michael J. Kamdar(President, Chief Executive Officer and Secretary)
BoardDavid Hwang(Director)Larry Stambaugh(Chairman of the Board of Directors)John Nicols(Director)Todd Peterson(Director)
Co-investors11.2 CapitalDCVC (Data Collective)iSelect FundAlexandriaArgonautic VenturesCasdin Capital+1 more
Neurona is a clinical-stage biotherapeutics company developing allogeneic, off-the-shelf regenerative neural cell therapies that integrate into neural circuits to treat chronic neurological disorders.
BiotechHealthtechSouth San Francisco, US
Cory Nicholas(Executive Officer, Director, Promoter)inJames Stutz(Executive Officer)inArnold Kriegstein(Director)
BoardPeter Svennilson(Director)inTim Kutzkey(Director)Ray Kelleher(Director)
Co-investorsBerkeley FrontierIaso VenturesThe Column GroupYsios CapitalAlexandriaFidelity Investments+7 more
Noah Medical develops robotic and software solutions for diagnostic bronchoscopy procedures, designed to enable earlier lung cancer diagnosis with improved accuracy.
HealthtechMedical DevicesRoboticsSilicon Valley, US
Jian Zhang(Founder & CEO)Enrique RomoFrank Grillo
Co-investors1955 CapitalChina Growth CapitalProsperity7 VenturesShangBay Capital LLC
Nucleix is a healthcare company developing diagnostic technology based on DNA/nucleic acid analysis for cancer detection.
BiotechDigital HealthHealthtechMedical Devices
Eli Frydman(President EMEA)
Co-investorsGefen CapitalOrbiMedRA CapitalBlackRockLilly Asia VenturesSands Capital Ventures
Co-investorsB Capital GroupB4 CapitalLAVLilly Asia VenturesNextech InvestRA Capital
Sciwind Biosciences is a commercial-stage biopharmaceutical company that discovers, develops, and delivers therapeutics focused on metabolic and weight management conditions, serving patients globally.
BiotechHealthtech
Portfolio news
latest coverage across their companiesMolecular Assemblies · leadsontrees.com · Apr 9, 2025
Frequently asked questions
- How many investments has LYFE Capital made?
- LYFE Capital has 16 tracked investments.
- What stage does LYFE Capital invest at?
- LYFE Capital invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does LYFE Capital focus on?
- LYFE Capital focuses on Biotech, Digital Health, Healthtech, Medical Devices, Robotics, Sector Agnostic.
- Where is LYFE Capital located?
- LYFE Capital is headquartered in Menlo Park, US.
- Does LYFE Capital lead rounds?
- LYFE Capital typically participates in rounds rather than leading them.
- Who does LYFE Capital co-invest with?
- LYFE Capital most often shares deals with 1955 Capital, B Capital Group, B4 Capital, among 10 tracked co-investors.
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.
Norwest Venture Partners is an investment firm whose growth equity team backs private, profitable, fast-growing companies, providing capital and hands-on support through its 'invited guest' approach.